Indeed, increased glutamine catabolism, (over)supplying the TCA cycle, was observed in pulmonary ECs of patients with a BMPR2 (bone morphogenetic receptor type II) mutation suffering chronic PAH (PAH classified as group I by WHO). Here, BMPR2 is linked to pulmonary arterial hypertension.